{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:27Z","timestamp":1791843207775,"version":"4.3.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>Low-grade oncocytic tumor (LOT) of the kidney is a recently recognized renal neoplasm with distinctive morphologic, immunophenotypic, and molecular features that distinguish it from other eosinophilic tumors such as oncocytoma and chromophobe renal cell carcinoma (chRCC). This study presents a comprehensive analysis of 20 LOTs from 19 patients, integrating clinicopathological, immunohistochemical, and genetic data. LOTs typically appeared as small, unilateral, well-circumscribed tumors with a tan-brown cut surface, composed of uniform eosinophilic cells with round nuclei and occasional perinuclear halos. Key histological hallmarks included an extensive capillary network and central edematous areas without necrosis or significant atypia. Immunohistochemically, all tumors showed strong diffuse CK7 positivity and CD117 negativity, with universal expression of GATA3, GPNMB, and L1CAM. Whole-exome and panel-based sequencing revealed recurrent mutations in the mTOR signaling pathway, including <jats:italic>MTOR<\/jats:italic>, <jats:italic>TSC1<\/jats:italic>, and <jats:italic>ATM<\/jats:italic> genes. mTORC1 activation was confirmed immunohistochemically in one case. No evidence of aggressive behavior or metastasis was observed during the follow-up period (median: 4.5\u00a0years). Comparative analysis demonstrated that LOT patients were diagnosed at an older age than those with chRCC and had smaller tumors overall. This study reinforces the notion that LOT is a distinct renal tumor entity with consistent morphology, immunoprofile, and mTOR-pathway-related genetic alterations. Despite overlapping features with other eosinophilic renal neoplasms, the specific immunohistochemical profile and indolent clinical course support LOT\u2019s classification as a unique diagnostic category.<\/jats:p>","DOI":"10.3389\/pore.2025.1612150","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T05:10:08Z","timestamp":1748841008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Low-grade oncocytic tumor of the kidney\u2014a clinical, pathological, and next generation sequencing-based study of 20 tumors"],"prefix":"10.3389","volume":"31","author":[{"given":"Alex","family":"Jenei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogl\u00e1rka","family":"P\u00f3sfai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borb\u00e1la","family":"D\u00e9nes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ron","family":"Somor\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrud","family":"Forika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Fintha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"M\u00e9sz\u00e1ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mi","family":"Kr\u00e1nitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Micsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korn\u00e9lia Veronika","family":"Eizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e1ndor","family":"Giba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"Semj\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Kelemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Cserni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Hajdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"\u00c1rvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Sztankovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sebesty\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanni","family":"S\u00e1nta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Engi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsombor","family":"Melegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Kuthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/his.13727","article-title":"New and emerging renal entities: a perspective post-WHO 2016 classification","volume":"74","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00428-024-03909-2","article-title":"Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists","volume":"485","author":"Mohanty","year":"2024","journal-title":"Virchows Arch"},{"key":"B4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.pathol.2022.09.002","article-title":"LOT and HOT \u2026 or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia","volume":"54","author":"Samaratunga","year":"2022","journal-title":"Pathology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.14670\/HH-18-435","article-title":"Low-grade oncocytic tumor (LOT) - a new renal entity ready for a prime time: An updated review","volume":"37","author":"Mansoor","year":"2022","journal-title":"Histol Histopathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41379-021-00906-7","article-title":"Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1","volume":"35","author":"Morini","year":"2022","journal-title":"Mod Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/his.14816","article-title":"Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity","volume":"82","author":"Williamson","year":"2023","journal-title":"Histopathology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-023-03673-9","article-title":"Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT","volume":"483","author":"Ricci","year":"2023","journal-title":"Virchows Arch"},{"key":"B9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000538705","article-title":"Colonic tubular adenoma with clear cell change: case report with whole-exome sequencing and updated review of the literature","volume":"91","author":"Ferenczi","year":"2024","journal-title":"Pathobiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.2147\/OTT.S196638","article-title":"Assessment of tumor mutation burden calculation from gene panel sequencing data","volume":"12","author":"Xu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41379-022-01057-z","article-title":"Do we need an updated classification of oncocytic renal tumors?: emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities","volume":"35","author":"Hes","year":"2022","journal-title":"Mod Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2021.04.013","article-title":"Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): incidence in a single institutional experience with clinicopathological and molecular characteristics","volume":"114","author":"Kravtsov","year":"2021","journal-title":"Hum Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00428-022-03283-x","article-title":"Low-grade oncocytic tumor of kidney harboring TSC\/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity","volume":"480","author":"Zhang","year":"2022","journal-title":"Virchows Arch"},{"key":"B15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/jclinpath-2021-207478","article-title":"Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute","volume":"75","author":"Akgul","year":"2022","journal-title":"J Clin Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification","volume":"12","author":"Siadat","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.semdp.2005.11.004","article-title":"An immunohistochemical approach to the differential diagnosis of renal tumors","volume":"22","author":"Skinnider","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.semnephrol.2019.04.005","article-title":"Intercalated cells of the kidney collecting duct in kidney physiology","volume":"39","author":"Rao","year":"2019","journal-title":"Semin Nephrol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100467","DOI":"10.1016\/j.modpat.2024.100467","article-title":"L1 cell adhesion molecule (L1CAM) expression and molecular alterations distinguish low-grade oncocytic tumor from eosinophilic chromophobe renal cell carcinoma","volume":"37","author":"Alghamdi","year":"2024","journal-title":"Mod Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1610852","DOI":"10.3389\/pore.2023.1610852","article-title":"Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations","volume":"29","author":"Chen","year":"2023","journal-title":"Pathol Oncol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"10668969241291885","DOI":"10.1177\/10668969241291885","article-title":"GATA3 expression in solid vimentin-negative eosinophilic renal epithelial tumors-a comprehensive study of 48 tumors","volume":"10","author":"Kwon","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1610831","DOI":"10.3389\/pore.2022.1610831","article-title":"Angiomyolipoma of the kidney-Clinicopathological analysis of 52 cases","volume":"28","author":"Fejes","year":"2023","journal-title":"Pathol Oncol Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s12253-019-00792-0","article-title":"Clinicopathological findings on 28 cases with XP11.2 renal cell carcinoma","volume":"26","author":"Kuthi","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.clgc.2023.11.008","article-title":"Prognosis and clinicopathological characters of adult TFEB-altered renal cell carcinoma: a single center experience of 18 cases","volume":"22","author":"Wu","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.semdp.2023.11.001","article-title":"Hereditary succinate dehydrogenase-deficient renal cell carcinoma","volume":"41","author":"Rogala","year":"2024","journal-title":"Semin Diagn Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","article-title":"Cellular functions of the protein kinase ATM and their relevance to human disease","volume":"22","author":"Lee","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1073\/pnas.0913860107","article-title":"ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS","volume":"107","author":"Alexander","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/0115680096250376231025062652","article-title":"Identification of ATM mutation as a potential prognostic biomarker for immune checkpoint inhibitors therapy","volume":"24","author":"Cui","year":"2024","journal-title":"Curr Cancer Drug Targets"},{"key":"B30","doi-asserted-by":"publisher","first-page":"23247096241286370","DOI":"10.1177\/23247096241286370","article-title":"Double Hit in Clear-Cell Renal Cell Carcinoma with Germline Pathogenic ATM Mutation and Somatic VHL Mutation","volume":"12","author":"Chan","year":"2024","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1016\/j.clgc.2019.01.003","article-title":"Low expression of ATM indicates a poor prognosis in clear cell renal cell carcinoma","volume":"17","author":"Ren","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"102808","DOI":"10.1016\/j.ctrv.2024.102808","article-title":"Targeting the ATM pathway in cancer: opportunities, challenges and personalized therapeutic strategies","volume":"129","author":"Lee","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41379-021-00923-6","article-title":"Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases","volume":"35","author":"Farca\u015f","year":"2022","journal-title":"Mod Pathol"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2025.1612150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T05:10:09Z","timestamp":1748841009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2025.1612150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":33,"alternative-id":["10.3389\/pore.2025.1612150"],"URL":"https:\/\/doi.org\/10.3389\/pore.2025.1612150","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"article-number":"1612150"}}